Seminars in Radiation Oncology
Volume 19, Issue 2 , Pages 106-111 , April 2009

Cancer Stem Cells, Hypoxia and Metastasis

  • Richard P. Hill

      Affiliations

    • Division of Applied Molecular Oncology, Ontario Cancer Institute/Princess Margaret Hospital, University Health Network, Toronto, Ontario, Canada
    • Department of Medical Biophysics, University of Toronto, Toronto, Ontario, Canada
    • Department of Radiation Oncology, University of Toronto, Toronto, Ontario, Canada
    • Corresponding Author InformationAddress reprint requests to Richard P. Hill, PhD, Ontario Cancer Institute, Princess Margaret Hospital, 610 University Avenue, Toronto, ON M5G2M9, Canada
    • ,
  • Delphine T. Marie-Egyptienne

      Affiliations

    • Division of Applied Molecular Oncology, Ontario Cancer Institute/Princess Margaret Hospital, University Health Network, Toronto, Ontario, Canada
    • Department of Medical Biophysics, University of Toronto, Toronto, Ontario, Canada
    • ,
  • David W. Hedley

      Affiliations

    • Division of Applied Molecular Oncology, Ontario Cancer Institute/Princess Margaret Hospital, University Health Network, Toronto, Ontario, Canada
    • Department of Medical Oncology, Princess Margaret Hospital, University Health Network, Toronto, Ontario, Canada
    • Department of Medical Biophysics, University of Toronto, Toronto, Ontario, Canada
    • Department of Medicine, University of Toronto, Toronto, Ontario, Canada

References 

  1. Visvader JE, Lindeman GJ. Cancer stem cells in solid tumors: Accumulating evidence and unresolved questions. Nat Rev Cancer. 2008;8:755–768
  2. Hill RP, Perris R. “Destemming” cancer stem cells. J Natl Cancer Inst. 2007;99:1435–1440
  3. Cairns RA, Khokha R, Hill RP. Molecular mechanisms of tumor invasion and metastasis: An integrated view. Curr Mol Med. 2003;3:659–671
  4. Chambers AF, Groom AC, MacDonald IC. Dissemination and growth of cancer cells in metastatic sites. Nat Rev Cancer. 2002;2:563–572
  5. Fidler IJ. The pathogenesis of cancer metastasis: The ‘seed and soil’ hypothesis revisited. Nat Rev Cancer. 2003;3:453–458
  6. Kiel MJ, Morrison SJ. Uncertainty in the niches that maintain haematopoietic stem cells. Nat Rev Immunol. 2008;8:290–301
  7. Raaijmakers MH, Scadden DT. Evolving concepts on the microenvironmental niche for hematopoietic stem cells. Curr Opin Hematol. 2008;15:301–306
  8. Miele L, Golde T, Osborne B. Notch signaling in cancer. Curr Mol Med. 2006;6:905–918
  9. Tung DC, Chao KS. Targeting hedgehog in cancer stem cells: How a paradigm shift can improve treatment response. Future Oncol. 2007;3:569–574
  10. Katoh M. Wnt signaling in stem cell biology and regenerative medicine. Curr Drug Targets. 2008;9:565–570
  11. D'Souza B, Miyamoto A, Weinmaster G. The many facets of Notch ligands. Oncogene. 2008;27:5148–5167
  12. Varjosalo M, Taipale J. Hedgehog: Functions and mechanisms. Genes Dev. 2008;22:2454–2472
  13. Vaupel P, Mayer A. Hypoxia in cancer: Significance and impact on clinical outcome. Cancer Metastasis Rev. 2007;26:225–239
  14. Vaupel P, Kelleher DK, Hockel M. Oxygen status of malignant tumors: Pathogenesis of hypoxia and significance for tumor therapy. Semin Oncol. 2001;28(Suppl 8):29–35
  15. Lanzen J, Braun RD, Klitzman B, et al. Direct demonstration of instabilities in oxygen concentrations within the extravascular compartment of an experimental tumor. Cancer Res. 2006;66:2219–2223
  16. Brurberg KG, Gaustad JV, Mollatt CS, et al. Temporal heterogeneity in blood supply in human tumor xenografts. Neoplasia. 2008;10:727–735
  17. Brurberg KG, Thuen M, Ruud EB, et al. Fluctuations in pO2 in irradiated human melanoma xenografts. Radiat Res. 2006;165:16–25
  18. Cardenas-Navia LI, Mace D, Richardson DF, et al. The pervasive presence of fluctuating oxygenation in tumors. Cancer Res. 2008;68:5812–5819
  19. Lunt SJ, Chaudary N, Hill RP. The tumor microenvironment and metastatic disease. Jun 10, 2008. 2008;Jun 10, [E-pub ahead of print]
  20. Gort EH, Groot AJ, van der Wall E, et al. Hypoxic regulation of metastasis via hypoxia-inducible factors. Curr Mol Med. 2008;8:60–67
  21. Sullivan R, Graham CH. Hypoxia-driven selection of the metastatic phenotype. Cancer Metastasis Rev. 2007;26:319–331
  22. Chan DA, Giaccia AJ. Hypoxia, gene expression, and metastasis. Cancer Metastasis Rev. 2007;26:333–339
  23. Harris AL. Hypoxia—A key regulatory factor in tumor growth. Nat Rev Cancer. 2002;2:38–47
  24. Semenza GL. Targeting HIF-1 for cancer therapy. Nat Rev Cancer. 2003;3:721–732
  25. Semenza GL. Hypoxia and cancer. Cancer Metastasis Rev. 2007;26:223–224
  26. Maynard MA, Ohh M. The role of hypoxia-inducible factors in cancer. Cell Mol Life Sci. 2007;64:2170–2180
  27. Mabjeesh NJ, Amir S. Hypoxia-inducible factor (HIF) in human tumorigenesis. Histol Histopathol. 2007;22:559–572
  28. Raval RR, Lau KW, Tran MG, et al. Contrasting properties of hypoxia-inducible factor-1 (HIF-1) and HIF-2 in Von Hippel-Lindau-associated renal cell carcinoma. Mol Cell Biol. 2005;25:5675–5686
  29. Liu YL, Yu JM, Song XR, et al. Regulation of the chemokine receptor CXCR4 and metastasis by hypoxia-inducible factor in non small cell lung cancer cell lines. Cancer Biol Ther. 2006;5:1320–1326
  30. Winter SC, Shah KA, Han L, et al. The relation between hypoxia-inducible factor (HIF)-1alpha and HIF-2alpha expression with anemia and outcome in surgically treated head and neck cancer. Cancer. 2006;107:757–766
  31. Dayan F, Roux D, Brahimi-Horn MC, et al. The oxygen sensor factor-inhibiting hypoxia-inducible factor-1 controls expression of distinct genes through the bifunctional transcriptional character of hypoxia-inducible factor-1α. Cancer Res. 2006;66:3688–3698
  32. Wouters BG, Koritzinsky M. Hypoxia signalling through mTOR and the unfolded protein response in cancer. Nat Rev Cancer. 2008;8:851–864
  33. Moeller BJ, Cao Y, Li CY, et al. Radiation activates HIF-1 to regulate vascular radiosensitivity in tumors: Role of reoxygenation, free radicals, and stress granules. Cancer Cell. 2004;5:429–441
  34. Prabhakar NR, Kumar GK, Nanduri J, et al. ROS signaling in systemic and cellular responses to chronic intermittent hypoxia. Antioxid Redox Signal. 2007;9:1397–1403
  35. Ezashi T, Das P, Roberts RM. Low O2 tensions and the prevention of differentiation of hES cells. Proc Natl Acad Sci U S A. 2005;102:4783–4788
  36. Cipolleschi MG, Dello Sbarba P, Olivotto M. The role of hypoxia in the maintenance of hematopoietic stem cells. Blood. 1993;82:2031–2037
  37. Parmar K, Mauch P, Vergilio R, et al. Distribution of hematopoietic stem cells in the bone marrow according to regional hypoxia. Proc Natl Acad Sci U S A. 2007;104:5431–5436
  38. Levesque JP, Winkler IG, Hendy J, et al. Hematopoietic progenitor cell mobilization results in hypoxia with increased hypoxia-inducible transcription factor-1 alpha and vascular endothelial growth factor A in bone marrow. Stem Cells. 2007;25:1954–1965
  39. D'Ippolito G, Diabira S, Howard GA, et al. Low oxygen tension inhibits osteogenic differentiation and enhances stemness of human Miami cells. Bone. 2006;39:513–522
  40. Grayson WL, Zhao F, Izadpanah R, et al. Effects of hypoxia on human mesenchymal stem cell expansion and plasticity in 3D constructs. J Cell Physiol. 2006;207:331–339
  41. Studer L, Csete M, Lee SH, et al. Enhanced proliferation, survival, and dopaminergic differentiation of CNS precursors in lowered oxygen. J Neurosci. 2000;20:7377–7383
  42. Morrison SJ, Csete M, Groves AK, et al. Culture in reduced levels of oxygen promotes clonogenic sympathoadrenal differentiation by isolated neural crest stem cells. J Neurosci. 2000;20:7370–7376
  43. Morrison SJ, Perez SE, Qiao Z, et al. Transient Notch activation initiates an irreversible switch from neurogenesis to gliogenesis by neural crest stem cells. Cell. 2000;101:499–510
  44. Lin Q, Lee YJ, Yun Z. Differentiation arrest by hypoxia. J Biol Chem. 2006;281:30678–30683
  45. Axelson H, Fredlund E, Ovenberger M, et al. Hypoxia-induced dedifferentiation of tumor cells—A mechanism behind heterogeneity and aggressiveness of solid tumors. Semin Cell Dev Biol. 2005;16:554–563
  46. Das B, Tsuchida R, Malkin D, et al. Hypoxia enhances tumor stemness by increasing the invasive and tumorigenic side population fraction. Stem Cells. 2008;26:1818–1830
  47. Platet N, Lin SY, Atifi ME, et al. Influence of oxygen tension on CD133 phenotype in human glioma cell cultures. Cancer Lett. 2007;258:286–290
  48. Barnhart BC, Simon MC. Metastasis and stem cell pathways. Cancer Metastasis Rev. 2007;26:261–271
  49. Keith B, Simon MC. Hypoxia-inducible factors, stem cells, and cancer. Cell. 2007;129:465–472
  50. Covello KL, Kehler J, Yu H, et al. HIF-2alpha regulates Oct-4: Effects of hypoxia on stem cell function, embryonic development, and tumor growth. Genes Dev. 2006;20:557–570
  51. Gidekel S, Pizov G, Bergman Y, et al. Oct-3/4 is a dose-dependent oncogenic fate determinant. Cancer Cell. 2003;4:361–370
  52. Nofziger D, Miyamoto A, Lyons KM, et al. Notch signaling imposes two distinct blocks in the differentiation of C2C12 myoblasts. Development. 1999;126:1689–1702
  53. Wilson A, Radtke F. Multiple functions of Notch signaling in self-renewing organs and cancer. FEBS Lett. 2006;580:2860–2868
  54. Gustafsson MV, Zheng X, Pereira K, et al. Hypoxia requires notch signaling to maintain the undifferentiated cell state. Dev Cell. 2005;9:617–628
  55. Koshiji M, Kageyama Y, Pete EA, et al. HIF-1α induces cell cycle arrest by functionally counteracting Myc. EMBO J. 2004;23:1949–1956
  56. Gordan JD, Bertout JA, Hu CJ, et al. HIF-2alpha promotes hypoxic cell proliferation by enhancing c-myc transcriptional activity. Cancer Cell. 2007;11:335–347
  57. Meyer N, Penn LZ. Reflecting on 25 years with MYC. Nat Rev Cancer. 2008;8:976–990
  58. Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 2006;126:663–676
  59. Maherali N, Sridharan R, Xie W, et al. Directly reprogrammed fibroblasts show global epigenetic remodeling and widespread tissue contribution (Cell stem). Cell. 2007;1:55–70
  60. Mani SA, Guo W, Liao MJ, et al. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell. 2008;133:704–715
  61. Ben-Porath I, Thomson MW, Carey VJ, et al. An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors. Nat Genet. 2008;40:499–507
  62. Morel AP, Lievre M, Thomas C, et al. Generation of breast cancer stem cells through epithelial-mesenchymal transition. PLoS ONE. 2008;3:e2888
  63. Weinberg RA. Twisted epithelial-mesenchymal transition blocks senescence. Nat Cell Biol. 2008;10:1021–1023
  64. Gavert N, Ben-Ze'ev A. Epithelial-mesenchymal transition and the invasive potential of tumors. Trends Mol Med. 2008;14:199–209
  65. Guarino M, Rubino B, Ballabio G. The role of epithelial-mesenchymal transition in cancer pathology. Pathology. 2007;39:305–318
  66. Thompson EW, Williams ED. EMT and MET in carcinoma—Clinical observations, regulatory pathways and new models. Clin Exp Metastasis. 2008;25:591–592
  67. Tse JC, Kalluri R. Mechanisms of metastasis: Epithelial-to-mesenchymal transition and contribution of tumor microenvironment. J Cell Biochem. 2007;101:816–829
  68. Turley EA, Veiseh M, Radisky DC, et al. Mechanisms of disease: Epithelial-Mesenchymal transition—Does cellular plasticity fuel neoplastic progression?. Nat Clin Pract Oncol. 2008;5:280–290
  69. Berx G, et al. Pre-EMTing metastasis?: Recapitulation of morphogenetic processes in cancer. Clin Exp Metastasis. 2007;24:587–597
  70. Yang MH, Wu MZ, Chiou SH, et al. Direct regulation of TWIST by HIF-1α promotes metastasis. Nat Cell Biol. 2008;10:295–305
  71. Sahlgren C, Gustafsson MV, Jin S, et al. Notch signaling mediates hypoxia-induced tumor cell migration and invasion. Proc Natl Acad Sci U S A. 2008;105:6392–6397
  72. Cannito S, Novo E, Compagnone A, et al. Redox mechanisms switch on hypoxia-dependent epithelial-mesenchymal transition in cancer cells. Carcinogenesis. 2008;29:2267–2278
  73. Cicchini C, Laudadio I, Citarella F, et al. TGFβ-induced EMT requires focal adhesion kinase (FAK) signaling. Exp Cell Res. 2008;314:143–152
  74. McLean GW, Carragher NO, Avizienyte E, et al. The role of focal-adhesion kinase in cancer—A new therapeutic opportunity. Nat Rev Cancer. 2005;5:505–515
  75. Avizienyte E, Frame MC. Src and FAK signalling controls adhesion fate and the epithelial-to-mesenchymal transition. Curr Opin Cell Biol. 2005;17:542–547
  76. Canel M, Secades M, Garzon-Arango M, et al. Involvement of focal adhesion kinase in cellular invasion of head and neck squamous cell carcinomas via regulation of MMP-2 expression. Br J Cancer. 2008;98:1274–1284
  77. Sawai H, Okada Y, Funahashi H, et al. Activation of focal adhesion kinase enhances the adhesion and invasion of pancreatic cancer cells via extracellular signal-regulated kinase-1/2 signaling pathway activation. Mol Cancer. 2005;4:37
  78. Imai T, Horiuchi A, Wang C, et al. Hypoxia attenuates the expression of E-cadherin via upregulation of SNAIL in ovarian carcinoma cells. Am J Pathol. 2003;163:1437–1447
  79. Esteban MA, Tran MG, Hartan SK, et al. Regulation of E-cadherin expression by VHL and hypoxia-inducible factor. Cancer Res. 2006;66:3567–3575
  80. Krishnamachary B, Zagzag D, Nagasawa H, et al. Hypoxia-inducible factor-1-dependent repression of E-cadherin in von Hippel-Lindau tumor suppressor-null renal cell carcinoma mediated by TCF3, ZFHX1A, and ZFHX1B. Cancer Res. 2006;66:2725–2731
  81. Pham NA, Magalhaes JM, Do T, et al. Activation of Src and Src-associated signaling pathways in relation to hypoxia in human cancer xenograft models. Int J Cancer. 2008;124:280–286
  82. Kaplan RN, Psaila B, Lyden D. Bone marrow cells in the ‘pre-metastatic niche': Within bone and beyond. Cancer Metastasis Rev. 2006;25:521–529
  83. Kaplan RN, Rafii S, Lyden D. Preparing the ‘soil’: The premetastatic niche. Cancer Res. 2006;66:11089–11093
  84. Kaplan RN, Riba RD, Zacharoulis S, et al. VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche. Nature. 2005;438:820–827
  85. Wels J, Kaplan RN, Rafii S, et al. Migratory neighbors and distant invaders: Tumor-associated niche cells. Genes Dev. 2008;22:559–574
  86. Hiratsuka S, Watanabe A, Aburatani H, et al. Tumor-mediated upregulation of chemoattractants and recruitment of myeloid cells predetermines lung metastasis. Nat Cell Biol. 2006;8:1369–1375
  87. Ceradini DJ, Gurtner GC. Homing to hypoxia: HIF-1 as a mediator of progenitor cell recruitment to injured tissue. Trends Cardiovasc Med. 2005;15:57–63
  88. Staller P, Sulitkova J, Lisztwan J, et al. Chemokine receptor CXCR4 downregulated by von Hippel-Lindau tumor suppressor pVHL. Nature. 2003;425:307–311
  89. Muller A, Homey B, Soto H, et al. Involvement of chemokine receptors in breast cancer metastasis. Nature. 2001;410:50–56
  90. Kucia M, Reca R, Miekus K, et al. Trafficking of normal stem cells and metastasis of cancer stem cells involve similar mechanisms: Pivotal role of the SDF-1-CXCR4 axis. Stem Cells. 2005;23:879–894
  91. Zipori D. The nature of stem cells: State rather than entity. Nat Rev Genet. 2004;5:873–878

 Supported by the Terry Fox Foundation.

PII: S1053-4296(08)00084-2

doi: 10.1016/j.semradonc.2008.12.002

Seminars in Radiation Oncology
Volume 19, Issue 2 , Pages 106-111 , April 2009

Article Tools

* Image Usage & Resolution